WOLVERINE ASSET MANAGEMENT LLC - THERAVANCE BIOPHARMA INC ownership

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of THERAVANCE BIOPHARMA INC
ValueSharesWeighting
Q2 2021$1,414,000
-93.3%
1,500,000
-92.7%
0.01%
-93.8%
Q1 2021$20,968,000
-8.1%
20,600,000
-14.5%
0.18%
+5.4%
Q4 2020$22,817,000
+7.2%
24,100,0000.0%0.17%
-11.1%
Q3 2020$21,294,000
-9.3%
24,100,0000.0%0.19%
-19.9%
Q2 2020$23,476,000
-1.0%
24,100,0000.0%0.24%
-31.4%
Q1 2020$23,717,000
-5.1%
24,100,0000.0%0.34%
+18.6%
Q4 2019$24,989,000
+11.6%
24,100,0000.0%0.29%
+2.1%
Q3 2019$22,397,000
+7.0%
24,100,0000.0%0.28%
+4.0%
Q2 2019$20,926,000
-10.8%
24,100,0000.0%0.27%
-14.7%
Q1 2019$23,451,000
-5.3%
24,100,0000.0%0.32%
+7.7%
Q4 2018$24,760,000
-13.3%
24,100,0000.0%0.30%
-10.5%
Q3 2018$28,543,000
+20.0%
24,100,0000.0%0.33%
+7.8%
Q2 2018$23,789,000
-2.8%
24,100,0000.0%0.31%
-2.8%
Q1 2018$24,481,000
-7.4%
24,100,0000.0%0.32%
+18.7%
Q4 2017$26,424,000
-10.2%
24,100,000
+0.3%
0.27%
-18.1%
Q3 2017$29,431,000
-9.3%
24,020,0000.0%0.33%
-20.9%
Q2 2017$32,436,000
+21.7%
24,020,000
+14.4%
0.41%
-0.5%
Q1 2017$26,657,000
+10.2%
21,000,0000.0%0.41%
+32.7%
Q4 2016$24,181,00021,000,0000.31%
Other shareholders
THERAVANCE BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Context Capital Management, LLC 25,388$23,544,0002.40%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 49,675,000$46,013,0001.22%
DeepCurrents Investment Group LLC 33,824,000$31,165,0000.93%
Aequim Alternative Investments LP 13,920,000$12,909,0000.50%
Maven Securities LTD 14,280,000$14,280,0000.46%
Saltoro Capital, LP 1,350,000$1,252,0000.44%
Baupost Group 30,000,000$27,640,0000.25%
TENOR CAPITAL MANAGEMENT Co., L.P. 5,500,000$5,182,0000.12%
ZAZOVE ASSOCIATES LLC 1,250,000$1,163,0000.10%
HBK INVESTMENTS L P 22,500,000$20,832,0000.08%
View complete list of THERAVANCE BIOPHARMA INC shareholders